Tamarack Advisers’s Medtronic MDT Stock Holding History

Tamarack Advisers’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75,000	Closed	-$8.32M	–	51
2022 Q1	$8.32M	Sell	75,000 -50,000	-40%	-$5.28M	3.94%	9
2021 Q4	$12.9M	Sell	125,000 -75,000	-38%	-$8.68M	5.32%	3
2021 Q3	$25.1M	Sell	200,000 -50,000	-20%	-$6.47M	7.92%	3
2021 Q2	$31M	Sell	250,000 -50,000	-17%	-$6.28M	8.79%	1
2021 Q1	$35.4M	Sell	300,000 -75,000	-20%	-$8.79M	7.27%	2
2020 Q4	$43.3M	Buy	375,000 +125,000	+50%	+$13.8M	9.02%	2
2020 Q3	$26M	Buy	250,000 +100,000	+67%	+$10M	8.01%	2
2020 Q2	$13.8M	Sell	150,000 -75,000	-33%	-$7.19M	3.83%	8
2020 Q1	$20.3M	Sell	225,000 -160,000	-42%	-$17M	7.68%	2
2019 Q4	$43.8M	Sell	385,000 -15,000	-4%	-$1.65M	10.02%	1
2019 Q3	$43.4M	Sell	400,000 -20,000	-5%	-$2.09M	11.32%	2
2019 Q2	$41.2M	Buy	420,000 +70,000	+20%	+$6.39M	12.52%	2
2019 Q1	$31.9M	Buy	350,000 +75,000	+27%	+$6.71M	12.66%	2
2018 Q4	$25M	Buy	275,000 +15,000	+6%	+$1.4M	10.2%	2
2018 Q3	$25.6M	Sell	260,000 -64,000	-20%	-$5.92M	7.3%	5
2018 Q2	$27.7M	Buy	324,000 +134,000	+71%	+$11.2M	9.29%	2
2018 Q1	$15.2M	Buy	190,000 +40,000	+27%	+$3.3M	7.25%	4
2017 Q4	$12.1M	Sell	150,000 -15,000	-9%	-$1.2M	6.61%	6
2017 Q3	$12.8M	Buy	165,000 +120,000	+267%	+$9.96M	7.86%	4
2017 Q2	$3.99M	Buy	+45,000	New	+$3.79M	2.33%	19
2016 Q4	–	Sell	-115,000	Closed	-$9.88M	–	33
2016 Q3	$9.88M	Sell	115,000 -54,000	-32%	-$4.71M	3.11%	15
2016 Q2	$14.7M	Sell	169,000 -81,000	-32%	-$6.55M	5.62%	6
2016 Q1	$18.8M	Sell	250,000 -250,000	-50%	-$18.8M	6.56%	7
2015 Q4	$38.5M	Buy	+500,000	New	+$37.6M	5.06%	7

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tamarack Advisers's MDT Position: Q2 2022 in Review

Tamarack Advisers sold out of Medtronic (MDT) in Q2 2022, closing a stake of 75,000 shares — an estimated $8.32M sold.

Tamarack Advisers first reported a position in MDT in Q4 2015 and held it in 24 quarters. The position peaked at $43.8M in Q4 2019. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Tamarack Advisers reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Tamarack Advisers sold 75,000 Medtronic shares in Q2 2022, an estimated $8.32M.
Tamarack Advisers first reported a position in Medtronic in Q4 2015 and held it in 24 quarters.
Tamarack Advisers's Medtronic position peaked at $43.8M in Q4 2019.
2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.